Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Case Comprehensive Cancer Center
University of Colorado, Denver
University of Colorado, Denver
Fox Chase Cancer Center
Fudan University
Fudan University
Peking University People's Hospital
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Western Regional Medical Center
Washington University School of Medicine